
GC19374
Verucerfont
Also known as 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine
Verucerfont is a corticotropin-releasing factor receptor 1 (CRF1) antagonist with IC50s of ~6·1, >1000 and >1000 nM for CRF1, CRF2, and CRF-BP, respectively
ChemicalCAS885220-61-1MW406.48FormulaC22H26N6O2
- CAS number
- 885220-61-1
- Molecular weight
- 406.48
- Formula
- C22H26N6O2
- Solubility
- DMSO : 86·7 mg/mL (213·29 mM)
- InChIKey
- VKHVAUKFLBBZFJ-SFHVURJKSA-N
- Catalogue number
- GC19374
- Brand
- GLPBIO
Computed properties PubChem CID 11596613 · XLogP 4.5 · TPSA 90.4 Ų · H-bond donors 1
- XLogP
- 4.5
- TPSA
- 90.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 6
- Heavy atoms
- 30
SMILES CC[C@@H](C1=NC(=NO1)C)NC2=CC(=NC3=C(C(=NN23)C)C4=C(C=C(C=C4)OC)C)C
Computed descriptors from PubChem (CID 11596613), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il